Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000623182 | SCV000741917 | likely pathogenic | Inborn genetic diseases | 2016-10-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001572673 | SCV003525387 | uncertain significance | not provided | 2024-04-16 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 204 of the GHSR protein (p.Ala204Glu). This variant is present in population databases (rs121917883, gnomAD 0.005%). This missense change has been observed in individual(s) with GFSR-related conditions (PMID: 14715843, 16511605, 25557026). ClinVar contains an entry for this variant (Variation ID: 7632). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GHSR protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects GHSR function (PMID: 16511605, 17596538, 17717076, 21084395). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
OMIM | RCV000008071 | SCV000028276 | pathogenic | Short stature due to growth hormone secretagogue receptor deficiency | 2006-03-01 | no assertion criteria provided | literature only | |
Laboratory of Diagnostic Genome Analysis, |
RCV001572673 | SCV001797405 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001572673 | SCV001953157 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |